Skip to main content
. 2021 Dec 31;19(1):424. doi: 10.3390/ijerph19010424

Table 3.

Patient outcomes before and after prolonged exposure to extreme cold.

Analyzed Parameter
(Unit of Measure)
Results before Exposure to Extreme Cold Results after Exposure to Extreme Cold Change Compared to the Result before (% of Change) Standard
RBC [×10^12/L] 4.74 4.55 −4.01 4.6–6.2
HGB [g/dL] 14.4 13.9 −3.47 14–18
HCT [%] 44.1 42.6 −3.40 42–52
MCV [fl] 93.1 93.7 0.64 82–94
MCH [pg] 30.5 30.6 0.33 27–32
MCHC [g/dL] 32.7 32.7 no change 30–38
CHCM [g/dL] 33.3 32.6 −2.10 31–37
RDW [%] 13 12.4 −4.62 11.5–14.5
HDW [g/dL] 2.48 2.51 1.21 2.2–3.2
WBC [×10^9/L] 4.18 3.28 −21.53 4–10
Neutrocytes [×10^9/L] 2.08 1.72 −17.31 2.2–7.0
Eosinocytes [×10^9/L] 0.19 0.1 −47.37 0.0–0.5
Basophils [×10^9/L] 0.05 0.04 −20.00 0.0–0.1
Lymphocytes [×10^9/L] 1.49 1.09 −26.85 1.0–3.5
Monocytes [×10^9/L] 0.29 0.27 −6.90 0.0–0.9
PLT [×10^9/L] 200 185 −7.50 150–400
MPV [fl] 10.3 9.6 −6.80 7.2–11.1
PCT [%] 0.21 0.18 −14.29 0.120–0.380
PDW [%] 65.9 69.4 5.31 28.0–60.0
Coagulology
Prothrombin activity [%] 92.17 110 19.34 80–130
INR 1.04 0.9 −13.46 0.85–1.15
aPTT [s] 25.7 26.9 4.67 20.0–36.0
Fibrinogen [g/L] 2.13 2.65 24.41 1.8–3.5
D-dimer [mg/L] 0.17 0.102 −40.00 <0.5
Biochemistry
Iron [umol/L] 23.3 17.2 −26.18 14.0–32.0
B12 [pg/mL] 406 365 −10.10 200–900
Total bilirubin [umol/L] 9.4 5.6 −40.43 2.0–21.0
ALP [U/L] 44.4 56.1 26.35
AspAT [U/L] 26.7 40.8 52.81 5–38
AlAT [U/L] 30.4 51.3 68.75 5–41
GGT [U/L] 13 12 −7.69 5–55
LDH [U/L] 179.6 171.3 −4.62 100–225
Total protein [g/L] 76.8 71.4 −7.03 64–83
Albumin [g/L] 48.2 44.2 −8.30 38.0–49.0
Alpha-1-globulins [g/L] 2.4 2.6 8.33 2.4–4.0
Alpha-2-globulins [g/L] 5.3 5.7 7.55 4.8–9.0
Beta-1-globulins [g/L] 5 4.8 −4.00 3.2–6.3
Beta-2-globulins [g/L] 3.8 3.4 −10.53 2.2–5.2
Gamma globulins [g/L] 12.2 10.7 −12.30 6.8–15.0
AG index 1.68 1.62 −3.57
IgG [g/L] 12.2 11.3 −7.38 6.9–14.0
IgA [g/L] 3.2 2.9 −9.38 0.9–4.1
IgM [g/L] 1.5 1.2 −20.00 0.3–2.1
CRP [mg/L] 0.21 0.26 23.81 <5.0
Prealbumins [g/L] 0.377 0.319 −15.38 0.210–0.410
CK [U/L] 239.3 259.9 8.61 24–198
CK-MB [U/L] 12.9 13.3 3.10 4–24
Total cholesterol [mmol/L] 6.29 5.92 −5.88 3.0–5.0
HDL [mmol/L] 1.1 1.41 28.18 >1.0
LDL [mmol/L] 4.9 4.31 −12.04 <3.0
TG [mmol/L] 1.82 1.46 −19.78 <1.7
Alpha-amylase [U/L] 30.7 30.3 −1.30 28–100
Lipase [U/L] 25 30.8 23.20 13–60
Glucose [mmol/L] 5.89 5.21 −11.54 3.9–5.5
HBA1C [%] 5.2 4.7 −9.62 4.0–6.5
Immunochemistry
Testosterone [nmol/L] 23.33 37.36 60.14 4.94–32.01
NTproBNP [pg/mL] 33.5 22.5 −32.84 ≤125
Troponin I [pg/mL] 10 10 no change 0.26.2
TSH [microIU/mL] 0.72 0.78 8.33 0.35–4.94
FT3 [pmol/L] 5.76 5.31 −7.81 2.63–5.70
FT4 [pmol/L] 15.58 11.44 −26.57 9.0–19.0
IL6 [pg/mL] 1.5 2.4 60.00 ≤7.0

Abbreviations: RBC, red blood cell; HGB, hemoglobin; HCT, hematocrit; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; CHCM, cellular hemoglobin concentration mean; RDW, red cell distribution width; HDW, hemoglobin distribution width; WBC, white blood cell; PLT, platelet; MPV, mean platelet volume; PCT, procalcitonin; PDW platelet distribution width; INR, international normalized ratio; aPTT, activated partial thromboplastin time; ALP, alkaline phosphatase; AspAT, aspartate aminotransferase; AlAT, alanine aminotransferase; GGT, gamma-glutamyltranspeptidase; LDH, lactate dehydrogenase; IgG, immunoglobulin G; IgA, immunoglobulin A; IgM, immunoglobulin M; CRP, C-reactive protein; CK, creatine kinase; CK-MB, creatine kinase MB, cardiac marker; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglyceride; HBA1C, glycohemoglobin; NTproBNP, B-type natriuretic peptide; TSH, thyroid-stimulating hormone; FT3, free triiodothyronine; FT4, free thyroxine; IL-6, interleukin 6.